The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
Open accessAbstract
BACKGROUND: Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent. METHODS: We randomly assigned, in a 2-by-2 factorial design, 25,086 patients with an acute coronary syndrome who were referred for an invasive strategy to either double-dose clopidogrel (a 600-mg loading dose on day 1, followed by 150 mg daily for 6 days and 75 mg daily thereafter) or standard-dose clopidogrel (a 300-mg loading dose and 75 mg daily thereafter) and either higher-dose aspirin (300 to 325 mg daily) or lower-dose aspirin (75 to 100 mg daily). The primary outcome was cardiovascular death, myocardial infarction, or stroke at 30 days. RESULTS: The primary outcome occurred in 4.2% of patients assigned to double-dose clopidogrel as compared with 4.4% assigned to standard-dose clopidogrel (hazard ratio, 0.94; 95% confidence interval [CI], 0.83 to 1.06; P=0.30). Major bleeding occurred in 2.5% of patients in the double-dose group and in 2.0% in the standard-dose group (hazard ratio, 1.24; 95% CI, 1.05 to 1.46; P=0.01). Double-dose clopidogrel was associated with a significant reduction in the secondary outcome of stent thrombosis among the 17,263 patients who underwent PCI (1.6% vs. 2.3%; hazard ratio, 0.68; 95% CI, 0.55 to 0.85; P=0.001). There was no significant difference between higher-dose and lower-dose aspirin with respect to the primary outcome (4.2% vs. 4.4%; hazard ratio, 0.97; 95% CI, 0.86 to 1.09; P=0.61) or major bleeding (2.3% vs. 2.3%; hazard ratio, 0.99; 95% CI, 0.84 to 1.17; P=0.90). CONCLUSIONS: In patients with an acute coronary syndrome who were referred for an invasive strategy, there was no significant difference between a 7-day, double-dose clopidogrel regimen and the standard-dose regimen, or between higher-dose aspirin and lower-dose aspirin, with respect to the primary outcome of cardiovascular death, myocardial infarction, or stroke. (Funded by Sanofi-Aventis and Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00335452.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Self-citationClinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
Authors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Guidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.013 · Cited by 1,510
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
King, S. B., Smith, S. C., Hirshfeld, J. W., Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188208 · Cited by 1,014
Fox, K. A. A., Mehta, S. R., Peters, R., Zhao, F., Lakkis, N., Gersh, B. J., & Yusuf, S. (2004) · Circulation · doi:10.1161/01.cir.0000140675.85342.1b · Cited by 835
Peters, R. J. G., Mehta, S. R., Fox, K. A. A., Zhao, F., Lewis, B. S., Kopecky, S. L., Diaz, R., Commerford, P. J., Valentin, V., & Yusuf, S. (2003) · Circulation · doi:10.1161/01.cir.0000091201.39590.cb · Cited by 706
Patti, G., Colonna, G., Pasceri, V., Pepe, L. L., Montinaro, A., & Di Sciascio, G. (2005) · Circulation · doi:10.1161/01.cir.0000161383.06692.d4 · Cited by 652
Intravenous Platelet Blockade with Cangrelor during PCI
Bhatt, D. L., Lincoff, A. M., Gibson, C. M., Stone, G. W., McNulty, S., Montalescot, G., Kleiman, N. S., Goodman, S. G., White, H. D., Mahaffey, K. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908629 · Cited by 648
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
Harrington, R. A., Stone, G. W., McNulty, S., White, H. D., Lincoff, A. M., Gibson, C. M., Pollack, C. V., Montalescot, G., Mahaffey, K. W., Kleiman, N. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908628 · Cited by 625
von Beckerath, N., Taubert, D., Pogatsa-Murray, G., Schömig, E., Kastrati, A., & Schömig, A. (2005) · Circulation · doi:10.1161/circulationaha.105.559088 · Cited by 623
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
King, S. B., Smith, S. C., Hirshfeld, J. W., Morrison, D. A., Williams, D. O., & Jacobs, A. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.002 · Cited by 612
Montalescot, G., Sideris, G., Meuleman, C., Bal-dit-Sollier, C., Lellouche, N., Steg, P. G., Slama, M., Milleron, O., Collet, J.-P., Henry, P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.090 · Cited by 527
Angiolillo, D. J., Shoemaker, S. B., Desai, B., Yuan, H., Charlton, R. K., Bernardo, E., Zenni, M. M., Guzman, L. A., Bass, T. A., & Costa, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.667741 · Cited by 447
MÜLLER, I., SEYFARTH, M., RÜDIGER, S., WOLF, B., POGATSA-MURRAY, G., SCHÖMIG, A., & GAWAZ, M. (2001) · Heart · doi:10.1136/heart.85.1.92 · Cited by 405
Hochholzer, W., Trenk, D., Frundi, D., Blanke, P., Fischer, B., Andris, K., Bestehorn, H.-P., Büttner, H. J., & Neumann, F. (2005) · Circulation · doi:10.1161/01.cir.0000160869.75810.98 · Cited by 398
Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm
Bassand, J.-P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm132 · Cited by 364
Cuisset, T., Frere, C., Quilici, J., Morange, P.-E., Nait-Saidi, L., Carvajal, J., Lehmann, A., Lambert, M., Bonnet, J.-L., & Alessi, M.-C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.049 · Cited by 343
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes
Yusuf, S., Mehta, S. R., Zhao, F., Gersh, B. J., Commerford, P. J., Blumenthal, M., Budaj, A., Wittlinger, T., & Fox, K. A. A. (2003) · Circulation · doi:10.1161/01.cir.0000051362.96946.15 · Cited by 303
ANGIOLILLO, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.036 · Cited by 303
ESC guidelines for percutaneous coronary interventions: reply
Silber, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi564 · Cited by 213
von Beckerath, N., Kastrati, A., Wieczorek, A., Pogatsa-Murray, G., Sibbing, D., Graf, I., & Schömig, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl489 · Cited by 205
[Guidelines for percutaneous coronary interventions].
Silber, S., Albertsson, P., Fernández‐Avilés, F., Camici, P. G., Colombo, A., Hamm, C. W., Jørgensen, E. O., Marco, J., Nordrehaug, J.-E., Rużyłło, W., et al. (2005) · PubMed · Cited by 201
Topol, E. J., Easton, D., Harrington, R. A., Amarenco, P., Califf, R. M., Graffagnino, C., Davis, S., Diener, H.-C., Ferguson, J., Fitzgerald, D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000084501.48570.f6 · Cited by 197
Mehta, S. R., Bassand, J., Chrolavicius, S., Díaz, R., Fox, K. A. A., Granger, C. B., Jolly, S. S., Rupprecht, H., Widimský, P., & Yusuf, S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.026 · Cited by 152
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
Harrington, R. A., Becker, R. C., Cannon, C. P., Gutterman, D. D., Lincoff, A. M., Popma, J. J., Steg, P. G., Guyatt, G. H., & Goodman, S. G. (2008) · CHEST Journal · doi:10.1378/chest.08-0691 · Cited by 145
Lotrionte, M., Biondi‐Zoccai, G., Agostoni, P., Abbate, A., Angiolillo, D. J., Valgimigli, M., Moretti, C., Meliga, E., Cuisset, T., Alessi, M., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.048 · Cited by 112
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
Metadata
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-09-02
- Volume
- 363
- Issue
- 10
- Pages
- 930-942
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2170949977
- Cited by
- 768
- References
- 39
- FWCI
- 71.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.